Sign inJoin waitlistJoin the waitlist

Dean Delmastro

Physician · Marshfield - Marshfield Medical Center

Credentials: · · · · ·

History

Marshfield - Marshfield Medical Center
Present

Hematology and Medical Oncology
1991–1994
University of South Alabama
1988–1991
Rush Medical College
1984–1988

Research

Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines
Cancer Research · 1994 · 168 citations
DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines
Cancer Chemotherapy and Pharmacology · 1997 · First of 5 authors · 64 citations
Phenotypic transformation of CD52(pos) to CD52(neg) leukemic T cells as a mechanism for resistance to CAMPATH-1H
Case report · Leukemia · 2002 · 17 citations

GS
Gene Shaw
1 paper
LB
Lee Brettman
1 paper
MS
Michael Solle
1 paper
RB
Ruemu Birhiray
1 paper

Clinical trials

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2039
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
2024–2030
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Site PI · Recruiting
University of Rochester
2023–2028
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032